| Date | Time | Source | Headline | Symbol | Company |
| 05/28/2010 | 1:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/28/2010 | 1:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/26/2010 | 10:00AM | Business Wire | Impax Laboratories Enters Into Development and Supply Agreement with IGI Laboratories | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/25/2010 | 4:14PM | Business Wire | Impax Laboratories Announces Voting Results from 2010 Annual Meeting of Stockholders | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2010 | 6:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2010 | 6:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2010 | 6:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2010 | 6:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2010 | 6:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/19/2010 | 10:21AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/14/2010 | 8:30AM | Business Wire | Impax Laboratories Receives Tentative FDA Approval for Generic Opana® ER 5, 7.5, 10, 15, 20, 30 and 40 mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/10/2010 | 8:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/10/2010 | 3:21PM | Edgar (US Regulatory) | Schedule 13G | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/10/2010 | 11:00AM | Business Wire | Impax Laboratories to Present at the Bank of America Merrill Lynch Health Care Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/04/2010 | 10:31AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/04/2010 | 7:00AM | Business Wire | Impax Laboratories Reports Significant Growth for the First Quarter 2010 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/03/2010 | 10:00AM | Business Wire | Impax Laboratories to Present at the Deutsche Bank 35th Annual Health Care Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/29/2010 | 9:00AM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to Fenoglide® 40 and 120 mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/15/2010 | 2:00PM | Business Wire | Impax Pharmaceuticals Announces Amendment of Co-Promotion Agreement | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/15/2010 | 9:30AM | Business Wire | Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson’s Disease | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/14/2010 | 6:01PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/14/2010 | 1:55PM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/08/2010 | 5:23PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/08/2010 | 8:30AM | Business Wire | Allen Chao, Ph.D. Elected to Impax Laboratories Board of Directors | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/06/2010 | 9:00AM | Business Wire | Impax Laboratories Schedules Conference Call for First Quarter 2010 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/29/2010 | 4:40PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/17/2010 | 9:30AM | Business Wire | Impax Laboratories to Present at the Barclays Capital 2010 Global Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/15/2010 | 9:30AM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to TRILIPIX® Delayed-Release Capsules, 135 mg and 45 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 03/09/2010 | 1:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |